KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Interest Expenses (2016 - 2025)

Astrana Health (ASTH) has disclosed Interest Expenses for 16 consecutive years, with $17.5 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 117.13% to $17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.9 million through Dec 2025, up 50.85% year-over-year, with the annual reading at $49.9 million for FY2025, 50.85% up from the prior year.
  • Interest Expenses hit $17.5 million in Q4 2025 for Astrana Health, down from $17.7 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $17.7 million in Q3 2025 to a low of $967000.0 in Q3 2021.
  • Historically, Interest Expenses has averaged $5.6 million across 5 years, with a median of $3.7 million in 2023.
  • Biggest five-year swings in Interest Expenses: crashed 60.79% in 2021 and later skyrocketed 204.66% in 2023.
  • Year by year, Interest Expenses stood at $1.1 million in 2021, then surged by 144.72% to $2.6 million in 2022, then surged by 110.81% to $5.4 million in 2023, then skyrocketed by 48.82% to $8.1 million in 2024, then skyrocketed by 117.13% to $17.5 million in 2025.
  • Business Quant data shows Interest Expenses for ASTH at $17.5 million in Q4 2025, $17.7 million in Q3 2025, and $7.4 million in Q2 2025.